This report contains market size and forecasts of Tenofovir Disoproxil Fumarate and Its Combination Drugs in Global, including the following market information:
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tenofovir Disoproxil Fumarate and Its Combination Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tenofovir Disoproxil Fumarate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tenofovir Disoproxil Fumarate and Its Combination Drugs include Alkem Laboratories, Anhui Biochem Pharmaceutical, Beijing SL Pharmaceutical, Bristol-Myers Squibb, Chengdu Brilliant Pharmaceutical, CHIA TAI TIANQING (CTTQ) Pharmaceutical, Cipla, Cisen Pharmaceutical and Dr Reddy's Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tenofovir Disoproxil Fumarate and Its Combination Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Segment Percentages, by Type, 2021 (%)
Tenofovir Disoproxil Fumarate
Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine
Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine
Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine
Tenofovir Disoproxil Fumarate/Emtricitabine
Lamivudine/Tenofovir Disoproxil Fumarate
Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tenofovir Disoproxil Fumarate and Its Combination Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tenofovir Disoproxil Fumarate and Its Combination Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkem Laboratories
Anhui Biochem Pharmaceutical
Beijing SL Pharmaceutical
Bristol-Myers Squibb
Chengdu Brilliant Pharmaceutical
CHIA TAI TIANQING (CTTQ) Pharmaceutical
Cipla
Cisen Pharmaceutical
Dr Reddy's Laboratories
Emcure Pharmaceuticals
Fujian Cosunter Pharmaceutical
Gilead Sciences
GlaxoSmithKline
Haisco Pharmaceutical
Hetero Drugs
Janssen Pharmaceutica (Johnson & Johnson)
Mylan Pharmaceuticals
Natco Pharma
Qilu Pharmaceutical
Sun Pharmaceutical Industries
Teva
Torrent Pharmaceuticals
United Laboratories
Veritaz Healthcare
Wockhardt Ltd
Zydus Cadila